BIOMARKER PAIRS FOR PREDICTING PRETERM BIRTH

The disclosure provides a pair of isolated biomarkers selected from the group consisting of IBP4/SHBG, IBP4/PSG3, IBP4/LYAM1, IBP4/IGF2, CLUS/IBP3, CLUS/IGF2, CLUS/LYAM1, INHBC/PSG3, INHBC/IGF2, PSG2/LYAM1, PSG2/IGF2, PSG2/LYAM1, PEDF/PSG3, PEDF/SHBG, PEDF/LYAMl, CD14/LYAM1, and APOC3/LYAM1, wherein...

Full description

Saved in:
Bibliographic Details
Main Authors FLICK, Jeff, POLPITIYA, Ashoka, KEARNEY, Paul, FLEISCHER, Tracey, GASSMAN, Andrew, BRADFORD, Chad, BONIFACE, John, Jay, CRITCHFIELD, Gregory, Charles, HICKOK, Durlin, Edward
Format Patent
LanguageEnglish
French
German
Published 14.02.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The disclosure provides a pair of isolated biomarkers selected from the group consisting of IBP4/SHBG, IBP4/PSG3, IBP4/LYAM1, IBP4/IGF2, CLUS/IBP3, CLUS/IGF2, CLUS/LYAM1, INHBC/PSG3, INHBC/IGF2, PSG2/LYAM1, PSG2/IGF2, PSG2/LYAM1, PEDF/PSG3, PEDF/SHBG, PEDF/LYAMl, CD14/LYAM1, and APOC3/LYAM1, wherein the pair of biomarkers exhibits a change in reversal value between pregnant females at risk for pre-term birth and term controls. Also provided is a method of determining probability for preterm birth in a pregnant female, the method comprising measuring in a biological sample obtained from the pregnant female a reversal value for at least one pair of biomarkers selected from the group consisting of IBP4/SFIBG, IBP4/PSG3, IBP4/LYAM1, IBP4/IGF2, CLUS/IBP3, CLUS/IGF2, CLUS/LYAM1, INHBC/PSG3, INHBC/IGF2, PSG2/LYAM1, PSG2/IGF2, PSG2/LYAM1, PEDF/PSG3, PEDF/SHBG, PEDF/LYAMl, CD14/LYAM1, and APOC3/LYAM1 to determine the probability for preterm birth in the pregnant female.
Bibliography:Application Number: EP20230193775